Valuation
- Market cap
- 339,270,000
- Revenue TTM
- $2,440,000
- Net income TTM
- $-101,340,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -4,153.28%
- Debt to equity
- 0.00
Trading
- Volume
- 18,774,100
- Avg volume
- 3,973,554
- Day's range
- $1.17 – $1.55
- Shares out
- 218,884,000
- Stochastic %K
- 100%
- Beta
- 3.21
- Analysts
- Sell
- Price target
- $2.30
Company profile
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and seque...
Show more
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 866 688 7374
- Website
- https://www.quantum-si.com
- Address
- 29 Business Park Drive, Branford, United States
Latest news
No headlines yet.
